SILODOSIN 4mg. IP

A new uroselective alpha-blocker that relaxes the muscles around the bladder exit and prostate gland, improves the ability to urinate. Alleviates lower urinary tract symptoms by improving bladder storage function and relieving the benign prostatic obstruction. (Yoshihisa Matsukawa, 2009) An effective and well-tolerated treatment for the relief of lower urinary tract symptoms associated with benign prostatic hyperplasia in the male population. (Christopher R Chapple, 2011) Exhibits good efficacy in improving nocturia and nocturnal polyuria in elderly patients. (Young Won Kim, 2015) Improves detrusor overactivity and obstruction grade in patients with benign prostatic hyperplasia. (Tomonori Yamanishi, 2010) A rapidly efficacious and safe agent in the treatment of benign prostatic hyperplasia in men. (Nadir I Osman, 2012) An effective agent that improves voiding and storage symptoms, maximum urinary flow rate, and health-related quality of life. (Keating, 2015) Offers prompt improvement in urinary symptoms and a reduced risk of postural hypotension. (Zhao-Jun Yu, 2020) More effective than tamsulosin in relieving nocturia, incomplete bladder emptying, and frequency. (Koch, 2015)